Carna Biosciences (カルナバイオサイエンス株式会社) is a clinical-stage biopharmaceutical company that develops small molecule drugs and provides drug discovery services. It offers kinase proteins and other protein products, assay kits, activity-based biochemical screening and profiling assay services, and cell-based assay services. The company also identifies and develops medicines for the treatment of cancer and inflammatory diseases using its kinase drug discovery platform, QuickScout.